S troke is the fifth most common cause of mortality in the United States, and the leading cause of disability. 1 Historically, minority races/ethnicities have experienced higher burden of stroke incidence and mortality, and stroke incidence and mortality rates have been decreasing in black individuals. [2] [3] [4] [5] [6] [7] Few studies have outlined the characteristics and clinical outcomes of stroke in the Asian American population.
As the most rapidly growing racial/ethnic group in the country, the Asian American population by 2050 is estimated to be 34 million. 8 Studies 2, 9, 10 show that Asian American individuals have higher proportionate morbidity and mortality from stroke and that Asian American/Pacific Islander individuals have higher death rates than white patients from primary intracerebral hemorrhage. A comparison of death rates from 2003 to 2010 found higher proportionate mortality from stroke in various Asian American subgroups compared with white patients, 10 which was similar to findings that Asian
Canadians had an increased prevalence of cardiovascular disease compared with Canadians of European origin.
11
Although Asian American individuals have been noted to receive intravenous tissue plasminogen activator (IV tPA) at greater frequency than other racial/ethnic groups, they have been observed to have subsequently higher rates of intracerebral hemorrhage and mortality. 12, 13 The Get With The Guidelines-Stroke (GWTG-Stroke) database collects clinical and quality measures for the purpose of quality improvement. We compared Asian American and white cohorts to ascertain differences in characteristics of acute ischemic stroke, clinical and functional outcomes, and adherence to quality and performance measures.
Methods
The GWTG-Stroke program is a voluntary national prospectively collected stroke quality improvement registry sponsored by the American Heart Association/American Stroke Association, initiated in 2003. The details of this registry and its components have been described previously.
14 All participating institutions were required to comply with local regulatory and privacy guidelines and, if required, to secure institutional review board approval. Because data were used primarily at the local site for quality improvement, sites were granted waiver of informed consent under the common rule. IQVIA (Parsippany, New Jersey) served as the registry coordinating center. The Duke Clinical Research Institute (Durham, North Carolina) served as the data analysis center; institutional review board approval was granted to analyze aggregate deidentified data for research. In this retrospective analysis, the study population consisted of patients with a primary diagnosis of acute ischemic stroke admitted to GWTG-Stroke hospitals between April 1, 2004 , and July 31, 2016. Patient self-identified race/ethnicity was recorded by hospital staff. The GWTG-Stroke program collects race as white, black or African American, Asian American, American Indian or Alaska Native, and Native Hawaiian or Pacific Islander. Hispanic ethnicity is recorded separately.
We restricted analysis to 2 mutually exclusive groups, namely, Asian American or white individuals. We assessed clinical presentation via the National Institutes of Health Stroke Scale (NIHSS) score, IV tPA use, and post-tPA complications (eg, intracerebral hemorrhage). Clinical outcomes were identified, including in-hospital mortality, length of stay, discharge home, ambulatory status at discharge, and modified Rankin Scale (mRS) score (the latter was assessed after 2012).
The following performance measures were assessed: onset to tPA by 3 hours among those with arrival within 2 hours, early antithrombotics within 24 hours, antithrombotics at discharge, anticoagulants for atrial fibrillation/atrial flutter at discharge, deep vein thrombosis (DVT) prophylaxis, statin at discharge among those with low-density lipoprotein cholesterol (LDL-C) level exceeding 100 mg/dL or not documented (to convert cholesterol level to millimoles per liter, multiply by 0.0259), smoking cessation counseling, defect-free care, and composite achievement measures. Quality measures were dysphagia screen, stroke education (since 2008), rehabilitation (since 2008), door to IV tPA within 60 minutes, LDL-C level documentation, intensive statin therapy, lipid-lowering medications among those with LDL-C level exceeding 100 mg/dL or not documented, IV tPA by 4.5 hours among those with arrival within 3.5 hours, door to computed tomography within 25 minutes, and reducing weight recommendation for those with a body mass index (calculated as weight in kilograms divided by height in meters squared) of 25 or higher.
Patient and hospital characteristics, clinical presentation, in-hospital treatments and complications, clinical outcomes, and quality-of-care measures were compared between Asian American and white patients. The median (25th and 75th percentiles) and mean percentages were reported for continuous and categorical variables, respectively. Because of the large sample size, small differences could be statistically, but not clinically, significant. Therefore, absolute standardized differences (multiplied by 100) were calculated to compare the characteristics in Asian American vs white patients; an absolute standardized difference greater than 10% was considered meaningful. Wilcoxon rank sum test and χ 2 test were used to compare continuous and categorical outcomes, respectively.
Multivariable logistic regression models assessed the association of Asian American race/ethnicity, clinical outcomes, and quality measures. Generalized estimating equations accounted for within-hospital clustering. The model adjusted for demographics, including age, female sex, insurance (no insurance vs Medicare, Medicaid, or other), and medical history (atrial fibrillation/atrial flutter, prior stroke or transient ischemic attack, coronary artery disease or prior myocardial infarction, carotid stenosis, diabetes, peripheral vascular disease, hypertension, smoking, dyslipidemia, heart failure, and prosthetic heart valve), as well as arrival during off-hours, arrival mode to the emergency department (emergency medical services, private transport, or transfer from an outside hospital), and hospital characteristics (number of beds, number of ischemic stroke discharges per year, number of annual IV tPA cases, region, academic or teaching hospital, Primary Stroke Center certification, and rural vs urban). The NIHSS score was considered a proxy for severity of stroke. Given the relatively high percentage of missing NIHSS score data (31.1%), the NIHSS score variable was not used in the primary model for outcomes other than the NIHSS score. Sensitivity analysis was conducted that included the NIHSS score in the adjustment model using the subsample that had the NIHSS score measured. Additional analyses performed on time trends are available in the eAppendix in the Supplement.
Statistical analyses were performed using a software program (SAS, version 9.4; SAS Institute Inc). All P values were 2 sided, with statistical significance at .05.
Results
The study population of 1 772 299 patients consisted of patients admitted to 2171 GWTG-Stroke hospitals with acute ischemic stroke between April 1, 2004 16 .3%). The overall cohort was 51.3% (n = 909 516) female. The most common insurance among patients was Medicare (52.5% [n = 866 024]), with data missing for 124 076. White patients were significantly more likely to have a history of atrial fibrillation/atrial flutter, coronary artery disease or prior myocardial infarction, carotid stenosis, peripheral vascular disease, smoking, heart failure, and elevated mean body mass index. Asian American patients were significantly more likely to have a history of diabetes, to be taking diabetic medication, and to have higher documented blood glucose, LDL-C, and glycated hemoglobin levels. The most common arrival mode for both groups was per emergency medical services (52.5% [n = 862 450]), with data missing for 130 912, but Asian American patients were more likely to arrive by private transport or taxi than white patients, while white patients were more likely to be transferred from an outside hospital than Asian American patients. ], P < .001). White patients were more likely to achieve an mRS score of 0 to 1. Available after 2012, the mRS score was assessed in 451 545 total patients, or approximately 25% of the total sample (19 356 Asian American patients and 432 189 white patients). Asian American patients were more likely to obtain performance measures, including antithrombotic or anticoagulant therapy, DVT prophylaxis, and defect-free care, and quality measures, including dysphagia screen, stroke education, rehabilitation, LDL-C level documentation, and intensive statin therapy. More Asian American patients than white patients had LDL-C level documentation (89.7% [n = 48 895] vs 87.6% [n = 1 255 260], P < .001), which could explain the greater use of intensive statin therapy at discharge by Asian American patients (38.5% [n = 8718] vs 30.3% [n = 148 298], P < .001). Asian American patients were also significantly more likely than white patients to meet the time measures of IV tPA by 3 hours among those with arrival within 2 hours, door to IV tPA within 60 minutes, and door to computed tomography within 25 minutes.
For those with a valid onset to arrival time (54.9% [n = 973 422] overall), Asian American patients (n = 35 219) took longer on average to arrive at the hospital after an ischemic stroke onset (mean, 554.3 minutes) than white patients (n = 938 203) (mean, 471.5 minutes). A lower proportion of Asian American patients than white patients arrived within 4.5 hours from stroke onset (51.5% vs 57.5%). Unadjusted analysis showed that Asian American patients had longer times from onset to arrival after acute ischemic stroke (odds ratio [OR], 0.79; 95% CI, 0.76-0.81; P < .001).
After adjustment for patient and hospital variables, Asian American race/ethnicity was again seen to be associated with more severe stroke presentation (NIHSS score ≥16) (OR, 1.35; 95% CI, 1.30-1.40; P < .001) ( Table 3) . However, unlike the unadjusted analysis, Asian American patients received less IV tPA than white patients (OR, 0.95; 95% CI, 0.91-0.98; P = .003) but still had more hemorrhagic complications within 36 hours (OR, 1.36; 95% CI, 1.20-1.55; P < .001), life-threatening serious systemic hemorrhage (OR, 1.32; 95% CI, 1.03-1.71; P = .03), and any complication after tPA (OR, 1.31; 95% CI, 1.18-1.46; P < .001). Asian American patients were again noted to have increased in-hospital mortality (OR, 1.14; 95% CI, 1.09-1.19;
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Clinical Care and In-Hospital Outcomes of Asian American Patients With Acute Ischemic Stroke P < .001), increased length of stay (OR, 1.17; 95% CI, 1.14-1.20; P < .001), decreased likelihood of achieving an mRS score of 0 to 1 (OR, 0.80; 95% CI, 0.76-0.83; P < .001), and now decreased likelihood to be ambulating independently at discharge (OR, 0.84; 95% CI, 0.79-0.90; P < .001). Despite this, they were still noted to be more likely to be discharged home, although this did not reach statistical significance. Asian American patients had better quality measure adherence overall than white patients, including rehabilitation (OR, 1.27; 95% CI, 1.18-1.36; P < .001), door to tPA within 60 minutes (OR, 1.14; 95% CI, 1.06-1.22; P < .001), and intensive statin therapy (OR, 1.14; 95% CI, 1.10-1.18; P < .001). Asian American race/ ethnicity was associated with better overall hospital care, including defect-free care, dysphagia screen, intensive statin therapy at discharge, and receipt of a reducing weight recommendation for those with body mass index of 25 or higher. After the NIHSS score sensitivity analysis, Asian American patients had lower in-hospital mortality than white patients (OR, 0.95; 95% CI, 0.91-0.99; P = .008), in contrast to the initial analyses. Further nuances in this analysis were that Asian American patient association with discharge home became significant (OR, 1.12; 95% CI, 1.06-1.19; P < .001) and that Asian American patients became significantly less likely to meet 2 different time measures (IV tPA by 3 hours among those with arrival within 2 hours and door to computed tomography within 25 minutes). Asian American patient association with life-threatening serious systemic hemorrhage after tPA was significant before the NIHSS score adjustment (OR, 1.32; 95% CI, 1.03-1.71; P = .03) but lost significance after adjustment (OR, 1.22; 95% CI, 0.93-1.61; P = .14).
Discussion
Using the nationwide GWTG-Stroke registry with more than 1.7 million Asian American and white patients with acute ischemic stroke, we found that Asian American patients had more severe strokes on presentation but were less likely to receive IV tPA. They also had lengthier hospital stays and were less likely to be ambulatory and disability free at discharge. These findings have important implications for improving the care and outcomes for Asian American patients with acute ischemic stroke.
Our results are notable on 2 levels. First, Asian American patients had more severe strokes on presentation, despite our findings that white patients tended to be older and had more prehospital vascular risk factors than Asian American patients, with the exception of diabetes. One hypothesis could be that white patients had their vascular risk factors managed more effectively; however, there was no difference in antihypertensive or cholesterol-lowering prestroke medication use between cohorts, and Asian American patients were more likely to be taking diabetic medications. A second hypothesis is that Asian American patients may be less likely to seek preventive care before stroke, and risk factors could have been undiagnosed. Studies [15] [16] [17] [18] have shown that Asian American patients are less likely to have a primary care provider and have lower overall health care expenditures than white patients; low-income Asian American individuals may be especially less likely to seek preventive care due to a variety of barriers, including language, financial costs, or other cultural factors. In our patient population, Asian American patients were more likely to have Medicaid insurance than white patients and were less likely to use emergency medical services for transport. A third hypothesis may have to do with stroke pathophysiology in Asian American individuals. More nuanced research is necessary to understand the difference in stroke severity seen in our study. A second notable observation from our study is that Asian American patients received less IV tPA than white patients. Other studies 19, 20 have shown that racial minority groups and lowerincome patients are less likely to receive IV tPA. Our Asian American patients were seen at the hospital slightly later than white patients and arrived more often by private transport. Given that hospital protocols use system practices (eg, prehospital notification by emergency medical services for stroke) and that IV tPA is a time-sensitive therapy, these factors could mean that Asian American patients were deemed ineligible to receive IV tPA. This is supported by the fact that Asian American patients were more likely than white patients to receive IV tPA within 60 minutes, although they were less likely to be treated by 3 hours if arrival was within 2 hours. Another hypothesis is that language barriers could have prevented Asian American patients from Tables 1 and 2 , age, sex, transfer from an outside hospital, number of ischemic stroke discharges per year, number of annual IV tPA cases, region, and Primary Stroke Center certification had complete data. Most other variables had missing less than 3%, except for insurance (7% missing) and arrival mode to emergency department (9% missing). Missing values on patient baseline characteristics were imputed to dominant level, and missing values on hospital variables were excluded in the multivariable models. Numbers and percentages were calculated based on data available.
b An absolute standardized difference greater than 10% was considered meaningful.
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receiving IV tPA. However, a study 21 showed that the NIHSS score is strongly associated with receiving tPA, outside of language preference. Yet another hypothesis is that due to stroke severity clinicians may have been hesitant to administer IV tPA. Patients with severe stroke (NIHSS score >25) are considered to have a relative contraindication, especially in an extended time window. 22, 23 In our study, however, Asian American patients still received less IV tPA than white patients after adjustment for stroke severity. A final hypothesis may have to do with stroke knowledge and recognition of stroke symptoms. Racial/ethnic minority groups have been shown to have decreased knowledge about strokes, which could lead to disparities in timely stroke presentation; cultural tailoring may be an effective approach to education. [24] [25] [26] Asian American patients in our study also had worse functional outcomes than white patients, defined by increased length of stay, less independent ambulation at discharge, and lower likelihood of an mRS score of 0 to 1. It is curious that the Asian American cohort did better than the white cohort in meeting in-house quality measures, such as dysphagia screening, but this did not translate into better functional outcomes. Although Asian American patients had higher levels of disability at discharge, they were still more likely to be discharged home than white patients, even after adjustment for stroke severity. This may represent the cultural implications of filial piety. It has been well established that in many Asian cultures older Asians prefer to be cared for at home by family, despite disability or prohibitive health issues. [27] [28] [29] However, studies 30, 31 have documented the changing needs of caretakers for stroke patients over time; the major features of stroke that influenced the care provided by caregivers were the NIHSS score, physical dependence, and length of stay in the hospital. Because Asian American patients in our study were more physically dependent, manifested more severe strokes, and had lengthier hospital stays than white patients, it would be relevant to compare our cohorts at a longer follow-up time, such as 6 months or 1 year. Because our Asian American cohort had lower incomes and were more likely to have Medicaid insurance, another hypothesis is that their options at discharge were more limited than those of the white cohort. Inpatient mortality seemed particularly influenced by severity of stroke. Initially, Asian American patients had greater in-hospital mortality than white patients; however, after sensitivity analysis for stroke severity, they had less mortality. One explanation could be that the higher stroke b Statistically significant at P < .05.
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Clinical Care and In-Hospital Outcomes of Asian American Patients With Acute Ischemic Stroke severity accounted for most of the higher in-hospital mortality. Another explanation could be that the better quality metrics Asian American patients experienced during their hospital stay improved their in-hospital mortality. Despite receiving less IV tPA than white patients, Asian American patients in our study had more symptomatic intracranial bleeding complications after receiving IV tPA. This is consistent with prior studies and lends credibility to several trials testing a lower dose of tPA for acute ischemic stroke in Asian patients. [32] [33] [34] [35] [36] Studies (mostly observational) in Asian countries have shown that lower doses of tPA are associated with fewer bleeding complications after administration, with similar results. However, a noninferiority trial in mostly Asian patients with acute ischemic stroke failed to show that the low-dose regimen was noninferior to the standard dose in reducing death or disability, although those in the lowdose tPA group had significantly fewer symptomatic intracranial hemorrhages. 37, 38 For now, all patients with acute ischemic stroke who are eligible are recommended to receive the standard dose of IV tPA (0.9 mg/kg), although future studies are warranted to observe which patients and at what dose might maximize efficacy, while minimizing harm.
Limitations
Limitations of this study include that the GWTG-Stroke program consists of voluntary participating hospitals, and quality of stroke care is likely to be higher than that in nonparticipating hospitals. Although larger, academic hospitals are overrepresented in the GWTG-Stroke program, an analysis of Medicare data 39 showed that GWTG-Stroke patients have demographics and medical histories similar to those of patients with ischemic stroke admitted to nonparticipating hospitals and the United States overall. In addition, the data entered into the GWTG-Stroke registry by participating hospitals has been found to be reliable by random audit. 40 Asian
American race/ethnicity includes individuals from multiple heritages, including Asian Indian, Chinese, Filipino, Korean, Japanese, Vietnamese, and other groups. Unfortunately, information on subgroups of Asian American patients was not available in the GWTG-Stroke registry during our study period, and we could not examine ischemic stroke care and outcomes specific to Asian American subgroups. Although race/ethnicity was self-reported, there also remains the potential for misclassification; the proportion of Asian American patients in the GWTG-Stroke cohort has been previously reported to be similar to that of a matched Medicare cohort. 41 In our study, the Asian American and white cohorts at baseline had significant demographic and clinical differences, including that the white group was older and more likely to have specific risk factors, such as atrial fibrillation and coronary artery disease. The hospitals at which the 2 cohorts were seen also differed in ischemic stroke volume, tPA use, and geographic region. Residual measured and unmeasured confounding may account for some of these findings. Because of the large sample size of the overall cohort, small differences became statistically significant. This could have inflated the importance of differences between groups, which may not have been clinically meaningful. The mRS score (measured after 2012) was only available in about one-quarter of our patient cohort and has limitations in how it can be used as a functional outcome. Finally, postdischarge outcomes were not available for analysis.
Conclusions
To our knowledge, this is the largest analysis to date to describe acute ischemic stroke in Asian American patients in terms of presentation, clinical and functional outcomes, and quality and process measures and to compare these findings with a white cohort. After risk adjustment, Asian American race/ethnicity was associated with more severe ischemic strokes, receipt of less IV tPA, and worse functional outcomes. Further research is necessary to better define interventions that can improve the disparities that Asian American patients experience in acute ischemic stroke. Role of the Funder/Sponsor: The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
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